Vetnostrum Animal Health Co., Ltd. (6936.TWO)
TWD 35.85
(0.28%)
TWD 35.85
(0.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 235.49 Million | 127.56 Million | 126.8 Million | 120.46 Million | - |
| Net Income | 113.03 Million | 131.01 Million | 133.56 Million | 130.91 Million | - |
| Depreciation & Amortization | 76.73 Million | 78.21 Million | 77.43 Million | 64.53 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 5.29 Million | 4.77 Million | - | - |
| Change in working capital | 71.47 Million | -61.4 Million | -67.11 Million | -49.83 Million | - |
| Other non-cash items | 1.43 Million | 2.79 Million | 2.38 Million | 2.06 Million | - |
| Investing Cash Flow | -15.78 Million | -17.82 Million | -39.06 Million | -68.58 Million | - |
| Investments in PPE | -15.48 Million | -22.05 Million | -42.23 Million | -68.75 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 5 Million | - | -5 Million |
| Other Investing Activities | -329 Thousand | 3.86 Million | -2.79 Million | -562 Thousand | - |
| Financing Cash Flow | -207.4 Million | -97.92 Million | -105.91 Million | -43.93 Million | - |
| Debt repayment | -120 Million | -60 Million | -25 Million | -45 Million | - |
| Dividends payments | -80.11 Million | -82.5 Million | -73.7 Million | -81.4 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 1.27 Million | 52.99 Million | - | - | - |
| Other Financing Activities | -8.55 Million | - | - | - | - |
| Accounts receivables | 14.5 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | 13.72 Million | -34.11 Million | -58.84 Million | -24.79 Million | - |
| Other working capital | 43.24 Million | - | - | - | - |
| Cash at beginning of period | 91.6 Million | 79.79 Million | 97.97 Million | 90.02 Million | - |
| Cash at end of period | 103.91 Million | 91.6 Million | 79.79 Million | 97.97 Million | - |
| Capital Expenditure | -15.48 Million | -22.05 Million | -42.23 Million | -68.75 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 12.3 Million | 11.81 Million | -18.18 Million | 7.95 Million | - |
| Free Cash Flow | 220 Million | 105.51 Million | 84.57 Million | 51.71 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 40.12 Million | 33.9 Million | 113.03 Million | 20.87 Million | 30.73 Million | 131.01 Million |
| Depreciation & Amortization | 19.22 Million | 18.97 Million | 76.73 Million | 19.27 Million | 19.41 Million | 78.21 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 5.29 Million |
| Change in working capital | -19.14 Million | -37.41 Million | 71.47 Million | 28.27 Million | 23.32 Million | -61.4 Million |
| Other non-cash items | 81 Thousand | 322 Thousand | 1.43 Million | 125 Thousand | 700 Thousand | 2.79 Million |
| Investing Cash Flow | -9.86 Million | -5.29 Million | -15.78 Million | -2.55 Million | -1.85 Million | -17.82 Million |
| Investments in PPE | -10.25 Million | -5.52 Million | -15.48 Million | -2.41 Million | -2.98 Million | -22.05 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 383 Thousand | 231 Thousand | -329 Thousand | -140 Thousand | 1.09 Million | 3.86 Million |
| Financing Cash Flow | -11.06 Million | -2.1 Million | -207.4 Million | -42.16 Million | -72.09 Million | -97.92 Million |
| Debt repayment | -10 Million | - | -120 Million | -40 Million | -70 Million | -60 Million |
| Dividends payments | - | - | -80.11 Million | - | - | -82.5 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 49 Thousand | 1.27 Million | - | - | 52.99 Million |
| Other Financing Activities | -1.06 Million | - | - | - | - | - |
| Accounts receivables | -30.7 Million | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -14.75 Million | -18.04 Million | 13.72 Million | 6.37 Million | 40.23 Million | -34.11 Million |
| Other working capital | 26.31 Million | - | - | - | - | - |
| Cash at beginning of period | 111.05 Million | 103.91 Million | 91.6 Million | 90.27 Million | 91.6 Million | 79.79 Million |
| Cash at end of period | 122.37 Million | 111.05 Million | 103.91 Million | 101.67 Million | 90.27 Million | 91.6 Million |
| Capital Expenditure | -10.25 Million | -5.52 Million | -15.48 Million | -2.41 Million | -2.98 Million | -22.05 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 11.31 Million | 7.14 Million | 12.3 Million | 11.4 Million | -1.33 Million | 11.81 Million |
| Free Cash Flow | 21.99 Million | 9.02 Million | 220 Million | 53.7 Million | 69.62 Million | 105.51 Million |
CLDI
APPF
0TIQ
RLHPF
RRDMF
TOUP